The Institute of Experimental Hematology investigates the biology of blood cell formation and function with a special focus on genetic cell modification as a new therapeutic modality.
Our research groups collaborate to form a portfolio ranging from the generation and expansion of stem cells to the control or enhancement of cell differentiation and function. We connect basic research and strong translational efforts in the field of molecular cell modification for the treatment of severe blood diseases, such as immune disorders and leukemia. The detection and prevention of risks associated with genetic cell modification and training of young scientists are important missions of our Institute.
The Institute of Experimental Hematology contributes to strong research networks of Hannover Medical School, including the DFG-funded cluster of excellence REBIRTH, the collaborative research center SFB738, and the Integrated Research and Treatment Center for Transplantation Medicine (IFB-Tx). Furthermore, we participate in the DFG-funded research priority program “mechanisms of gene vector entry and persistence” (SPP1230), several network projects supported by the BMBF, DAAD and Federal State of Lower Saxony (R2N) as well as integrated projects of the EU Horizon 2020 (SCID-NET, RECOMB) and the ERC.
Prof. Dr. med.
Axel Schambach, PhD
Medizinische Hochschule Hannover
Institut Experimentelle Hämatologie
- OE 6960 -
Tel.: +49 511 532 - 5170/6067
Fax: +49 511 532 - 6068